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The perineuronal net (PNN) is a mesh-like proteoglycan structure on the neuronal surface which is involved in regulating plasticity.
The PNN regulates plasticity via multiple pathways, one of which is direct regulation of synapses through the control of AMPA
receptor mobility. Since neuronal pentraxin 2 (Nptx2) is a known regulator of AMPA receptor mobility and Nptx2 can be
removed from the neuronal surface by PNN removal, we investigated whether Nptx2 has a function in the PNN. We found that
Nptx2 binds to the glycosaminoglycans hyaluronan and chondroitin sulphate E in the PNN. Furthermore, in primary cortical
neuron cultures, the addition of NPTX2 to the culture medium enhances PNN formation during PNN development. These
ﬁndings suggest Nptx2 as a novel PNN binding protein with a role in the mechanism of PNN formation.
1. Introduction
The perineuronal net (PNN) is a mesh-like extracellular
matrix (ECM) structure formed on the surface of neurons
to regulate plasticity. It appears at the closure of critical
periods [1–4]. A critical period is a stage of high plasticity
during brain development, when neurons form or prune syn-
apses to consolidate an eﬃcient network [5]. After the closure
of these periods the capacity for plasticity is reduced, at which
point the PNN is fully formed [3]. The PNN consists of a
hyaluronan (HA) backbone [6, 7], to which are bound a vari-
ety of chondroitin sulphate proteoglycans (CSPGs), such as
aggrecan, versican, brevican, and neurocan [8]. The core pro-
teins of CSPG are decorated with chondroitin sulphate (CS)
glycosaminoglycan (GAG) chains [9, 10]. The CSPGs are
bound stably to HA by hyaluronan and proteoglycan link
proteins (HAPLNs) [8, 11, 12], and the structure is further
stabilised by tenascin R binding to the C-termini of the
CSPGs [13, 14]. Several enzymes are known to break down
the PNN. Both chondroitinase ABC (chABC) [4, 15] and
hyaluronidase [16, 17] remove the PNN from the surface of
the neurons and induce a renewed capacity for plasticity.
For example, when the PNN is removed in the visual cortex,
ocular dominance plasticity can be reopened [4].
The PNN regulates plasticity through several pathways
[18]. Firstly, the PNN functions as a physical barrier between
the neuronal surface and the extracellular space. The PNN
buﬀers ions [19] and protects neurons from oxidative stress
[20] and toxic proteins [21]. Secondly, the PNN acts through
its binding partners, such as orthodenticle homeobox 2
(Otx2) and semaphorin-3A (Sema3A). Otx2 is known to
bind the PNN, after which it is internalized and functions
as a transcription factor to regulate the maturation of neu-
rons in the visual cortex [22, 23]. When the PNN is removed,
Otx2 is no longer internalized. Sema3A is a chemorepulsive
protein [24]. When it is bound to the PNN, it confers an
additional inhibition to the PNN and repels approaching
axons [24, 25]. Thirdly, the PNN limits lateral diﬀusion of
membrane-bound proteins, such as α-amino-3-hydroxy-5-
methyl-4-isoxazolepropionic acid (AMPA) receptors [26].
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The molecular interactions of the PNN are not yet fully
known, and improving the knowledge on PNN regulation
by its interacting molecules may allow manipulation of the
PNN for plasticity enhancement.
The PNN is attached to only a subset of neurons [7,
27–32]. In the cortex, parvalbumin-positive GABAergic
fast-spiking interneurons (PV-INs) are the main group of
neurons that possess a PNN [33, 34]. PV-INs receive signals
from large groups of neurons [1], and their PNN allows them
to regulate plasticity. When CSPGs are digested in the cortex
using chABC, electrophysiological measurements showed
that inhibitory activity is reduced [35]. The balance between
inhibitory and excitatory signals was altered, and the pat-
tern of activity resembled the juvenile state of the cortex
[35]. This suggests that PNNs are important for balancing
inhibitory and excitatory signals. Thus, manipulation of
PNNs might help to restore balance in the brain of patients
with plasticity dysfunctions [36], such as epilepsy [37] or
schizophrenia [38].
Neuronal pentraxin 2 (Nptx2, also known as Narp) is an
immediate early gene expressed in the central nervous
system [39]. Nptx2 is a calcium-dependent lectin, which
accumulates at excitatory synapses where it regulates
AMPA receptor mobility [40]. Nptx2 KO mice are viable
and fertile but show a reduction in spontaneous ﬁring rat-
ing of PV-INs [41]. Furthermore, in Nptx2 KO mice, the
critical period for ocular dominance plasticity does not
close [42]. The role of Nptx2 in critical period closure
[42] overlaps with the function of the PNN [1, 4]. Interest-
ingly, it has been shown that treatment with chABC to
digest the CSs in the PNN removes Nptx2 from the surface
of neuronal dendrites [41]. These ﬁndings suggest that
Nptx2 may interact with the PNN. Here, we show that
Nptx2 binds PNN GAGs and enhances PNN formation.
These results suggest that Nptx2 is a potential regulator
for PNN formation.
2. Materials and Methods
2.1. Chemicals. For immunohistochemistry, virus injection,
neuronal cultures and Western Blots, the following are
used: goat anti-Nptx2 (Santa Cruz, sc-12125), chicken
anti-NeuN (Millipore, abn91), rabbit anti-myc-tag (OriGene,
TA100029), rabbit anti-parvalbumin (Abcam, ab11427), bio-
tinylated WFA (Sigma-Aldrich, L1516), mouse anti-6X his-
tag (Abcam, ab18184), Hoechst (Thermo Fisher, H3570),
his-tag NPTX2 protein (R&D Systems, 10889), chABC
(Sigma-Aldrich, C3667), test hyase (Sigma-Aldrich, H3506),
strep hyase (Sigma-Aldrich, H1136), and lenti-cmv-Nptx2
lentivirus (107TU/mL, OriGene, MR206833L1V).
2.2. Virus Injection. All experiments were conducted in
accordance with the United Kingdom Animals (Scientiﬁc
Procedures) Act (1986). All animals were housed in standard
housing conditions in a room with a 12-hour light-dark
cycle. The animals were housed in groups of 2-4 animals
per cage. The animals were fed ad libitum and had unre-
stricted access to water. To allow for the visualization of
Nptx2 in the brain, 1 μL lenti-cmv-Nptx2-myc lentivirus
(CMV promoter, DDK-myc tag, 107TU/mL) (OriGene)
was injected in the right somatosensory cortex (AP: -1, ML:
1.5, DV: -1) of ﬁve 3-month-old female Listar hooded rats.
Rats were ﬁrst anaesthetised with isoﬂurane after which the
virus injection was performed at a rate of 500nL/2 minutes.
After 18 days, the rats were sacriﬁced and perfused.
2.3. Immunohistochemistry. Rats were perfused with 4%
paraformaldehyde (PFA), tissues dissected and postﬁxed at
4°C for 24 hours in 4% PFA. The brain tissue was then cryo-
protected in a 30% sucrose (Thermo Fisher) in PBS. The tis-
sue was then sectioned on a cryostat (Leica CM 3050S) into
free-ﬂoating sections at 20 μm thickness, which were pre-
served in PBS with 0.1% w/v sodium azide at 4°C. To stain
the tissue slices, they were ﬁrst washed 3 times in PBS and
then put in blocking buﬀer containing 3% horse serum,
0.1% bovine serum albumin (BSA), and 1% Tween-20 in
1X PBS. Subsequently, incubation of primary antibodies took
place for 16 hours at 4°C. Primary antibodies are as follows:
1 : 100 rabbit anti-myc-tag (OriGene), 1 : 200 anti-NeuN
(Millipore), and 1 : 250 WFA (PNN marker, Sigma-Aldrich).
After another three washes with PBS-T, incubation of appro-
priate secondary antibody at a concentration of 1 : 500 mixed
with 1 : 10000 Hoechst (Thermo Fisher) in 1X PBS took place
for one hour at RT. After three washes with 1X Tris-sodium
chloride buﬀer (TNS), the slices were mounted on slides
(twin frost glass slides, Thermo Scientiﬁc). To preserve the
signal, FluorSave Reagent (Calbiochem) was applied to all
slices and left to dry for 24 hours.
2.4. Neuronal Dissections and Cultures. Embryos from a
Sprague Dawley rat were collected at embryonic day 18.
Their heads were harvested and preserved in Hanks’ bal-
anced salt solution (HBSS). Cortices were dissected and
treated with papain to allow for the separation of neurons.
DNAse (Sigma-Aldrich) was applied to remove free DNA,
after which neurons were washed with HBSS and ﬁltered
(Thermo Fisher, 40 μm cell strainer). The neurons were
plated at 120,000 per imaging dish (Greiner Bio-One,
8.7 cm2 surface), which had been coated with poly-D-lysine
(Sigma-Aldrich). The neurons were maintained in culture
by replacing half of the medium (consisting of 100 μL
200mM L-glutamine (Gibco), 800μL GS21 (AMS Biotech-
nology Limited, Abingdon, UK) in 40mL neuralQ medium
(Life Technologies)) every week. To investigate the eﬀect of
NPTX2 on the PNN, the medium was enriched with
40 ng/mL NPTX2 (R&D Systems, human NPTX2 expressed
and puriﬁed) from 14 days in vitro (DIV) onwards. To inves-
tigate the eﬀect of PNN removal in the presence of exogenous
NPTX2 on the neuronal surface, neurons were treated with
chABC (Sigma-Aldrich, 0.2U/mL ﬁnal concentration) in
100mM ammonium acetate at pH 8.0 or Streptomyces
hyaluronidase (Sigma-Aldrich, 60U/mL in 0.002M ﬁnal
concentration) in sodium acetate at pH 6.0, 1 : 10 diluted
in medium. Half of the neuronal medium was replaced with
the enzyme mixture, and the cells were placed back in the
incubator at 37°C to incubate the enzymes for 30 minutes.
Neurons were ﬁxed with 4% PFA for 15 minutes to allow
for staining. The neurons were stained with biotinylated
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WFA (Sigma-Aldrich) 1 : 250, mouse anti-his-tag antibody
(Abcam) 1 : 100, rabbit anti-parvalbumin antibody (Abcam)
1 : 250, and Hoechst (Thermo Fisher) 1 : 10000. The imaging
was performed on a confocal microscope (Leica DM 600B) at
20x.
2.5. Automated Analysis of PNNs with R. Images were
captured on a confocal microscope (Leica). The settings
used were as follows: 1024 × 1024 format, xyz acquisition,
speed at 400Hz, no pinhole, and no bidirectional imaging.
Four lasers were used: 405nm, 43% open, and 1004 gain for
Hoechst staining; 488 nm, 45% open, and 593 gain for
WFA staining; 532 nm, 46% open, and 1020 gain for
Nptx2-myc tag staining; 635 nm, 42% open, and 946 gain
for NeuN staining. Individual PNNs (n ≈ 20) were automat-
ically extracted frommicroscope images (×40, taken on a sin-
gle confocal plane) using a novel methodology developed in
R. In this method, images were uploaded in R in .tiﬀ format.
The script, based on Rowlands et al., identiﬁes the PNN cir-
cular shapes in the WFA channel, after which it switches to
the Hoechst channel to control whether the identiﬁed circle
was around a cell [43]. For individual PNNs, the area in
which the PNN is WFA positive is selected. Subsequently,
the mean intensity for the WFA staining in the selected area
is measured. The script compares this intensity with the
intensity in the comparison channel, in this case the channel
for the myc-tag, in the same region. The intensity in both
channels was compared to investigate correlation between
intensity in the WFA and the myc-tag channel.
2.6. Sequential Buﬀer Treatment to Isolate PNN Molecules.
Homogenized 3-month-old rat brains were treated as
described in [3]. In short, after homogenization with a Potter
Elvehjem homogenizer to preserve cellular integrity, brains
were treated with sequential buﬀers to dissolve molecules
from the ECM (buﬀer 1 : 50mM Tris buﬀer saline with
2mM ethylenediaminetetraacetic acid at pH 7.0) and the
cytoplasm and membrane (buﬀer 2 : 0.5% Triton X-100 in
buﬀer 1), molecules contained by ionic interactions (buﬀer
3 : 1M NaCl in buﬀer 2), and PNN molecules (6M urea in
buﬀer 2), sequentially. The sequential buﬀer treatment
ensures that the ECM molecules, cytoplasm and membrane
molecules, and the molecules contained with ionic interac-
tions are removed before puriﬁcation of PNN molecules
takes place. The samples were treated to preserve proteins
with protease inhibitors (Roche) or GAGs with pronase
(Roche) followed by TCA and diethyl ether puriﬁcation.
2.7. Western Blot. The protein quantities in the protein sam-
ples were determined with a bicinchoninic acid kit (Thermo
Fisher), and equal protein quantity of each sample was run
on an 4-12% SDS-PAGE gel (Invitrogen) at 120V and trans-
ferred to a PVDF membrane (Invitrogen). 400 ng of NPTX2
protein (R&D Systems) was run as a positive control. After
transfer, the blots were probed overnight at 4°C with 1 : 200
goat anti-NPTX2 antibody (Santa Cruz).
2.8. ELISA.After puriﬁcation of the samples with the sequen-
tial buﬀer treatment, the GAG concentration in each sample
was quantiﬁed with cetylpyridinium chloride (CPC) turbi-
dimetry [44]. Pure samples of individual GAGs were pur-
chased from Seikagaku. Each GAG was biotinylated to a
ﬁnal concentration of 0.02mg/mL GAG. The amount of
biotin was quantiﬁed for each sample to ensure equal bio-
tinylation. Nptx2 protein was incubated on plates with high
binding capacity (Santa Cruz) for 16 hours, after which the
GAGs were incubated. Streptavidin alkaline phosphatase
was allowed to bind to the biotin groups on the GAGs.
The quantity of bound biotin was determined with para-
nitrophenyl phosphate, catalyzed by the phosphatase to
produce phenolate of which the wavelength was measured
at 405nm.
2.9. GENSAT and Allen Brain Atlas. The Gene Expression
Nervous System Atlas (GENSAT) was used to explore the
expression pattern of Nptx2. Bacterial Artiﬁcial Chromo-
some engineering was applied to express an enhanced green
ﬂuorescent protein (EGFP) gene upstream of the Nptx2 gene.
Images were taken from the database available at http://www
.gensat.org/GeneProgressTracker.jsp?gensatGeneID=2078.
The Allen Brain Atlas was used to explore in situ hybridiza-
tion images of Nptx2 on male mice at p56 (Nptx2-RP_
051214_01_H10–coronal, © 2010 Allen Institute for Brain
Science, Allen Human Brain Atlas, available from http://
human.brain-map.org.).
2.10. scRNA-Seq in Visual Cortex. Violin representation of
scRNA-Seq in 14236 single cells from the visual sensory pri-
mary cerebral cortex in mice 56 days old. Data are from the
Allen Institute (ﬁle reference VISp_14236_20180912). On
the top 13 subclasses are 4 GABAergic (Lamp5, Vip, Sst,
and Pvalb), 8 glutamatergic (layer 2/3 IT IntraTelencephalic
excitatory neurons, layer 4 excitatory neurons, layer 5 IT,
layer 6 IT, layer 5 PT Pyramidal Tract excitatory neurons,
NP Near Projecting excitatory neurons, layer 6 CT corti-
cothalamic excitatory neurons, layer 6b excitatory neurons),
and 1 astrocyte in various colors according to the code
color of Tasic et al. [45]. On vertical left genes detected;
Gad2 marker for interneurons; Slc17a7 marker for excit-
atory neurons; Gaj1 marker for astrocytes; Lamp (lyso-
somal-associated membrane protein family, member 5),
Vip (vasoactive intestinal polypeptide), Sst (Somatostatin),
Pvalb (Parvalbumin) four markers delineating four sub-
classes of interneurons: Sema3a, Sema3e, Nptx1, and Nptx2.
Median values are black dots, and values within rows are
normalized between 0 and the maximum expression value
for each gene (right edge of each row) and displayed on a
log10 scale.
2.11. Statistics. The analysis of the intensity of the PNN
staining in the brain was performed in R with a previously
published methodology [43]. The correlation between the
intensity of the WFA channel and the myc-tag channel was
tested with Spearman’s correlation test. The intensity of both
channels was measured as a mean intensity for the PNN
identiﬁed in the WFA channel (n ≈ 20, on 5 animals in total).
The analysis of the PNN staining on cultures was performed
by measuring the PNN surface area and intensity in ImageJ,
after which the Nptx2-treated neurons were compared with
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the untreated neurons in Origin Pro (N = 20). The ELISA
results were analysed in Origin Pro with a one-way ANOVA
(N = 3, each ELISA repeated three times).
3. Results
3.1. Localization of Nptx2 to PNNs. Previous literature sug-
gests that Nptx2 may mediate its action through interaction
with PNNs [41]. However, currently in the literature, there
is no direct evidence demonstrating an interaction between
Nptx2 and PNNs. To investigate this potential link between
them, we set out to localize Nptx2 in the adult rat brain.
However, none of the commercially available antibodies gave
consistent results that could clearly be diﬀerentiated from
background. In order to examine the subcellular localization
of Nptx2 in the brain and to circumvent the problems
encountered with the antibodies, we used lentiviral injections
to overexpress Nptx2 protein tagged with c-myc in the cortex
of adult rats.
Rats were injected with the lenti-cmv-Nptx2-myc at
3 months of age, and their brains were stained 18 days post
injection to locate the expressed myc-tagged Nptx2 by stain-
ing with an anti-myc antibody. We injected the lenti-cmv-
Nptx2-myc into the somatosensory cortex since there is
extensive PNN literature in this region [32, 46]. There were
twomain patterns of myc-tagged Nptx2 staining. The pattern
of the anti-myc staining varied across neurons: some neurons
were positive for myc-tag colocalization with WFA in the
typical appearance of PNNs and also contained intracellu-
lar dotty vesicular-shaped staining, while other neurons
had myc staining on their PNNs but no signs of intracel-
lular staining (Figure 1(a)). It is possible that the dotty
vesicle staining was caused by endosomal processes as well
as vesicles. There were also many cells which had the
intracellular vesicular-shaped pattern but showed no Nptx2
staining in the PNN (Figure 1(a) white circle on left image).
Of the PNN-positive neurons (determined by WFA), 66%
were positive for myc staining on their PNN, and 29%
showed the intracellular vesicle-shaped myc staining pattern
(Figures 1(d) and 1(e)). Within cells, there was a particulate
staining with a vesicular appearance (Figure 1(a), white
arrow, and Figure 1(c)). Around cells, the myc staining
surrounded cells and proximal dendrites (Figure 1(c)). This
staining colocalized with the PNN marker WFA and was
never found in neurons without WFA staining. The colocali-
zation between the extracellular myc-tag staining and the
WFA staining was quantiﬁed with an in-house PNN analysis
program written in R [43]. A correlation coeﬃcient of 0.816
was found, which indicates that the myc-tagged Nptx2
indeed locates to the PNN on neurons (Figure 1(b)). These
data show that myc-tagged Nptx2 partially associates with
PNNs and that the Nptx2 diﬀuses from or gets secreted by
Nptx2-producing cells to PNN-bearing cells where it binds
or is sequestrated.
To investigate the regional expression of Nptx2, it was
necessary to visualize Nptx2 expression in the brain. Due to
the lack of a good Nptx2 antibody for immunohistochemis-
try, we sought to use the online Gene Expression Nervous
System Atlas (GENSAT) [47] to investigate Nptx2 expres-
sion. GENSAT is an NIH-funded, publicly available gene
expression atlas of the mouse central nervous system. The
protocol applied to provide the images for the atlas is a Bac-
terial Artiﬁcial Chromosome (BAC) engineering system. An
EGFP gene is inserted upstream of the ATG start codon of
the gene of interest. This method allows for the visualization
of cells which express the gene of interest. We investigated
the expression ofNptx2 in the cortex with the GENSAT data-
base. Nptx2 is expressed by neurons in the cortex of the
mouse at P7 (Figure 2(a)). Expression of Nptx2 is still present
in the cortex at adult age in reduced quantities. In the Allen
Brain Atlas [48], in situ hybridization images of adult male
mice are available (Figure 2(b)) for visualizing RNA expres-
sion directly. In the Allen Brain Atlas images, Nptx2 is
expressed in the adult mouse cortex, with a high level in layer
2 (Figure 2(b)). An RNA sequencing experiment measured
levels of Nptx2 in the cortex. It was found that Nptx2 is
mostly expressed by intratelencephalic neurons in the cortex
as well as corticothalamic neurons, vasoactive intestinal pep-
tide (VIP), and somatostatin- (SST-) expressing neurons
(Figure 2(c)). Interestingly, to this date, these neurons are
not known to form PNNs. However, since Nptx2 is secreted
by neurons, it would be possible for Nptx2 to diﬀuse through
the ECM to bind to PNNs on neighbouring neurons. Here,
the role of PNNs could be acting as a local “chelator,” pre-
venting Nptx2 from further dispersion through the cortex.
Interestingly, the idea that a PNN-binding molecule can be
produced in one place then diﬀuse to another place in order
to bind to PNNs has been previously described for the tran-
scription factor Otx2. Beurdeley and colleagues showed that
Otx2 is produced and secreted from the choroid plexus,
travels to the visual cortex, binds to the disulphated CS-E
sugars in CS-GAGs, and aﬀects PNN maturation locally
[23, 49]. Nptx2 might also diﬀuse from one neuron to
another, over shorter distances. The combined results from
Figures 1 and 2 suggest that Nptx2 is expressed (Figure 2)
and secreted in the cortex by a variety of excitatory neurons
and interneurons, which allows Nptx2 to diﬀuse and reach
PNN-positive neurons (Figure 1).
3.2. Binding of Nptx2 to PNN Components. In order to bind to
PNNs after its secretion from distant cells, Nptx2 must bear a
speciﬁc binding aﬃnity for certain PNN component(s). We
next sought to investigate the structures in PNNs which
enable the binding of Nptx2. Most of the known PNN bind-
ing proteins have been shown to bind to the CS-GAG chains
in the PNN [23, 24]. We therefore ﬁrst investigated whether
Nptx2 binds to the various forms of GAGs present in PNNs.
PNN molecules were puriﬁed from rat brain homogenates
using a sequential buﬀer puriﬁcation method [3, 9]. This
method allows for the separation of molecules from the
diﬀerent compartments of the ECM (1) buﬀer soluble,
(2) detergent soluble, (3) charge-bound, and ﬁnally (4) stable
urea-soluble fraction that contains mostly PNN molecules
(fractions 1-4). These fractions were investigated by Western
blots probed with anti-Nptx2 antibody. Bands corresponding
to Nptx2 (47 kDa) were observed in fractions 2, 3, and 4, sug-
gesting the presence of Nptx2 on neuronal membranes and
in the PNN fraction (Figure 3(e)). This ﬁnding implies that
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Nptx2 is produced in the adult CNS and that at least some of
it is tightly bound to PNNs.
In order to conﬁrm the binding of Nptx2 to PNN compo-
nents, we developed a glycan-ELISA using puriﬁed NPTX2
(expressed from the human NPTX2 gene). GAGs were iso-
lated from diﬀerent brain fractions and conjugated with bio-
tin. Human NPTX2 was immobilised at the bottom of the
ELISA plates; biotinylated GAG chains isolated from diﬀer-
ent brain fractions were allowed to bind. The results showed
that NPTX2 preferentially binds the fraction 4 GAGs which
come predominantly from PNNs, but much weaker to GAGs
isolated from other fractions (Figure 3(a)). To conﬁrm
whether this result was due to binding of NPTX2, unbiotiny-
lated HA was incubated on immobilised NPTX2 before incu-
bation of biotinylated PNN glycans. This competition ELISA
showed binding of PNN glycans was signiﬁcantly decreased
after HA incubation (Figure 3(d)). These results suggest that
NPTX2 binds the PNN by interacting with PNN GAGs.
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Figure 1: Colocalization of myc-tagged Nptx2 and PNNs. 3-month-old rats were injected with lenti-cmv-Nptx2 into the somatosensory
cortex to express myc-tagged Nptx2. Perfused tissue was cut in 20 μm sections and stained with 1 : 250 WFA to identify PNNs, 1 : 100
myc-tag antibody to identify the myc-tagged Nptx2 protein expressed by the lenti-cmv-Nptx2, and 1 : 200 NeuN antibody to identify
neurons. (a) Representative images of the somatosensory cortex stained for WFA (green), myc-tag (red), and Hoechst (blue). In the left
image, the white circle shows a neuron with intracellular myc-tagged Nptx2, but not on the cell membrane. The red circle shows a neuron
with myc-tagged Nptx2 intracellularly and overlapping with the PNN. The white arrow points at the dotty myc-tag staining which is
suggestive of vesicle staining. In the right image, the white circle shows a neuron which contains myc-tagged Nptx2 colocalizing with the
PNN but shows no signs of intracellular myc-tagged Nptx2. (b) A correlation graph for the intensity of the myc-tag channel and the WFA
channel is presented. A correlation analysis of WFA staining intensity and myc staining intensity revealed a correlation of 0.816 which
indicates a high level of intensity correlation of the two channels in the PNN area. (c, d) The WFA staining for PNNs (green) is
overlapping with the myc-tagged Nptx2 staining (red). (e) An overview of the number of neurons which are expressing the myc-tagged
Nptx2 and which are positive for myc-tagged Nptx2 staining on their PNN. Intracellular myc-tag signal-positive neurons and PNN myc-
tag signal-positive neurons were calculated. All images were taken in the somatosensory cortex (scale bar = 20μm).
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Figure 2: Nptx2 is expressed in the cerebral cortex. (a) These images were taken from the Gene Expression Nervous System Atlas. Bacterial
Artiﬁcial Chromosome engineering was applied to express an EGFP gene upstream of theNptx2 gene. High expression of Nptx2 was found in
the cerebral cortex of mice at P7. Low expression was found in the cerebral cortex of adult mice, at P42. Low to no expression was found in the
cerebral cortex of mice at E15.5. These ﬁndings indicate that expression of Nptx2 is high during perineuronal net development, after which it
is reduced. The black arrows indicate neurons which express Nptx2 (scale bar = 1mm). (b) These images were taken from the Allen Brain
Atlas. The images were produced with in situ hybridization for Nptx2 on male mice at p56. They show that expression of Nptx2 is present
in adult mice in the cortex: Nptx2-RP_051214_01_H10–coronal, © 2010 Allen Institute for Brain Science, Allen Human Brain Atlas,
available from http://human.brain-map.org. (c) Violin representation of scRNA-Seq in 14236 single cells from the visual sensory primary
cerebral cortex in mice 56 days old. Data are from the Allen Institute (ﬁle reference VISp_14236_20180912). On the top 13 subclasses are
4 GABAergic (Lamp5, Vip, Sst, and Pvalb), 8 glutamatergic (layer 2/3 IT IntraTelencephalic excitatory neurons, layer 4 excitatory
neurons, layer 5 IT, layer 6 IT, layer 5 PT Pyramidal Tract excitatory neurons, NP Near Projecting excitatory neurons, layer 6 CT
corticothalamic excitatory neurons, layer 6b excitatory neurons), and 1 astrocyte in various colors according to the code color of Tasic
et al. [45]. On vertical left genes detected; Gad2 marker for interneurons; Slc17a7 marker for excitatory neurons; Gaj1 marker for
astrocytes; Lamp (lysosomal-associated membrane protein family, member 5), Vip (vasoactive intestinal polypeptide), Sst (Somatostatin),
Pvalb (Parvalbumin), four markers delineating four subclasses of interneurons: Sema3a, Sema3e, Nptx1, and Nptx2. Median values are
black dots, and values within rows are normalized between 0 and the maximum expression value for each gene (right edge of each row)
and displayed on a log10 scale.
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Figure 3: Continued.
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Our previous work showed that semaphorin-3A, another
PNN binding molecule, binds to PNN via CS-E GAG chains
[24]. To investigate which GAG chains are responsible for
the binding of NPTX2, the NPTX2 ELISA was repeated with
pure GAG samples from commercial sources, with predom-
inant sulphation patterns, including CS-A to CS-E, HA,
and heparan sulphates (HS). The results showed that NPTX2
binds with high aﬃnity to CS-E and HA (Figure 3(b)) and
with a weaker aﬃnity to HS than to CS-B, CS-C, and CS-D.
There is no binding to CS-A. These ﬁndings indicate that
NPTX2 binds the PNN preferentially through CS-E and HA.
Next, we further characterised which GAG chains bind to
NPTX2, by digesting the bound PNN GAGs with diﬀerent
GAG-digesting enzymes, including a CS-digesting enzyme,
chondroitinase ABC (chABC), a HA-digesting enzyme,
Streptomyces hyaluronidase (strep hyase), and a CS/HA-
Control
Hoechst WFA
WFA WFA WFA
his-tag Nptx2
his-tag Nptx2 his-tag Nptx2 his-tag Nptx2
HoechstWFA his-tag Nptx2 Hoechst WFA his-tag Nptx2
Chondroitinase Hyaluronidase
(h)
Figure 3: Nptx2 binds to the PNN. (a) Sequential buﬀer treatment of homogenized brain tissue was applied to purify the GAGs in the four
separate samples. The GAGs were randomly biotinylated to allow for detection with streptavidin alkaline phosphatase on a custom-made
NPTX2 ELISA plate. NPTX2 binds preferentially to PNN GAGs (p = 2:38E − 4). (b) To investigate which PNN GAGs can bind NPTX2,
an ELISA was performed with biotinylated samples of puriﬁed GAGs. The applied GAGs were chondroitin sulphates (CS) A, B, C, D, and
E, hyaluronan (HA), and heparan sulphate (HS). NPTX2 binds signiﬁcantly to HA and CS-E. ELISA results were analysed with ANOVA
(p = 2:01E − 4). (c) To investigate which of the PNN GAGs are responsible for the binding of NPTX2 to PNN GAGs, an NPTX2 ELISA
bound by the PNN GAG fraction was treated with the enzymes chondroitinase ABC, Streptomyces hyaluronidase, and testicular
hyaluronidase for one hour. All these enzymes were able to signiﬁcantly reduce the signal of the bound PNN GAGs, which indicates that
all enzymes break GAG bonds responsible for the binding of PNN GAGs to NPTX2. This result indicates that both, CS-E and HA in the
PNN GAG sample, bind to NPTX2 on the plate (p = 2:21E − 4). (d) To conﬁrm whether PNN glycan binding to NPTX2 could be blocked
in a competition ELISA, one set of wells was treated with unbiotinylated HA before exposure to biotinylated PNN glycans. The
hyaluronan indeed blocked the PNN glycans from binding (p = 0:008). (e) Sequential buﬀer treatment of homogenized rat brain tissue
was applied to purify extracellular molecules (1), membrane molecules (2), molecules contained by ionic interactions (3), and PNN
molecules (4). The samples were run on a Western blot, alongside a commercial NPTX2 control sample, at 120V on a 4-12% gel. Nptx2
was found in samples 2, 3, and 4. This result suggests that Nptx2 is located on the membrane, contained by ionic interactions and in the
PNN. (f–h) Cortical neurons from E18 rat brains were cultured to reach 35DIV. Neurons were treated with chondroitinase ABC or
Streptomyces hyaluronidase for 30 minutes. Neurons were ﬁxed with 4% PFA for 20 minutes. After blocking for 1 hour, neurons were
incubated with WFA and his-tag antibody to stain for the his-tagged NPTX2. Appropriate secondary antibodies were applied, and three
wash steps were performed after each step. Representative images of neurons are shown (h). The relative Nptx2 his-tag intensity (f) and
WFA PNN intensity (g) were signiﬁcantly reduced after treatment with chondroitinase ABC or Streptomyces hyaluronidase (n = 20,
ANOVA, p = 5:24E − 8 p = 0:039, resp.). These ﬁndings indicate that both enzymes successfully removed the PNN from the neuronal
surface and this removal of the PNN resulted in a removal of the exogenous Nptx2 protein from the neuronal surface (scale bar = 20 μm).
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digesting enzyme, testicular hyaluronidase (test hyase).
While chABC and strep hyase provide speciﬁc digestions of
CS or HA, respectively, test hyase digests both HA and CS
groups and could provide insights if both GAGs are involved.
We ﬁrst bound NPTX2 to the plates, then allowed the PNN
GAGs to bind to the NPTX2, after which the GAG-
digesting enzymes were applied. The results showed that an
enzymatic cleavage by chABC, test hyase, and strep hyase
resulted in a signiﬁcant reduction of signal of the bound
PNN GAGs (Figure 3(c)). This suggests that the interaction
between NPTX2 and PNN GAGs is mediated by both CSs
and HA.
The binding of NPTX2 to the PNN was further investi-
gated in vitro using E18 cortical neuronal cultures. Cultures
were matured until 35DIV. NPTX2 with a his-tag was added
to the medium to allow for visualization of potential binding
of NPTX2 in the culture. NPTX2 was observed on the surface
on neurons, forming a typical punctate PNN pattern in vitro
(Figure 3(h), control). To conﬁrm the involvement of HA
and CS in the binding, the GAGs were then cleaved enzymat-
ically on live cultures with chABC or strep hyase. Treatment
with chABC and strep hyase reduced PNN staining on the
neuronal surface (Figures 3(g) and 3(h)). At the same time,
the staining for the his-tag Nptx2 on the neuronal surfaces
was also signiﬁcantly reduced (Figures 3(f) and 3(h)). These
results indicate that exogenous NPTX2 binds to PNNs and
can be removed from the neuronal surface by enzymatic
digestion of CS and HA. Digesting either the CS chains and
the HA chains is suﬃcient to signiﬁcantly reduce his-tag
NPTX2 staining from the PNN, which indicates that these
GAG chains are responsible for the binding of NPTX2 to
the neuronal surface.
3.3. Nptx2 and PNN Formation. Nptx2 has previously been
shown to regulate AMPA receptor mobility [40], and Nptx2
KOmice demonstrate persistent plasticity in the visual cortex
[42]. In order to investigate if Nptx2 binding to nascent
PNNs is related to PNN formation and maturation, we
cultured E18 cortical neurons in the presence of NPTX2
(14-28DIV) until their maturation, a stage when PNNs start
to enwrap the surface of neurons and can be visualized by
WFA staining. We and others have previously mapped out
the developmental proﬁle of PNNs in cortical neurons in cul-
ture [50]. PNNs began to show a punctate pattern between 14
and 21DIV and continued to mature >45DIV. We thus
started the NPTX2 treatment at 14DIV, a stage prior to
PNN development. The neurons were imaged at 28DIV
because PNN formation has not yet been completed at that
time in control neurons [50]. Treatment of neurons with
40 ng/mL NPTX2 signiﬁcantly enhanced the number of
PNNs on neurons in the culture at 28DIV (Figures 4(a)–
4(c)). The relative PNN size, measured by area, was also sig-
niﬁcantly increased when stained with WFA (Figures 4(a),
4(b), 4(d), and 4(e)). The amount of PNN-positive PV-INs
was quantiﬁed to investigate the maturation level of the
PV-INs. In control cultures, 25-35% of PV-INs had started
to form a PNN at 28DIV, while in NPTX2-treated cultures
35-45% of PV-INs had started to form a PNN, which sug-
gests PV-INs were more mature after NPTX2 treatment.
These results indicate that NPTX2 enhances PNN formation
in cultured neurons.
4. Conclusion
The aim of this study was to examine the association of
Nptx2 with PNNs; we identiﬁed the binding partners of
Nptx2 in PNNs and examined the eﬀect of Nptx2 on PNN
formation. To study the possible association of Nptx2 with
PNNs in vivo, we injected a lentivirus expressing myc-
tagged Nptx2 into the brain of 3-month-old rats and visual-
ized its location. This method was chosen since it was not
possible to stain for endogenous Nptx2. Transfection eﬃ-
ciency was high, and Nptx2 appeared to be localized intracel-
lularly. Nptx2 was also observed to colocalize with WFA-
positive PNNs. Some neurons which showed colocalization
of Nptx2 with PNNs also contained intracellular Nptx2;
however, there were also neurons showing colocalization of
Nptx2 with PNNs without intracellular expression of Nptx2.
This suggests that Nptx2 can diﬀuse through the ECM from
cells that produce it and then bind to PNNs. The colocaliza-
tion was quantiﬁed with a new automated R script demon-
strating a very close anatomical association between Nptx2
and PNNs [43]. Furthermore, the correlation between the
WFA staining and the staining for the myc-tag is suggestive
of a quantitative correlation between the PNN and Nptx2:
the denser the PNN the more Nptx2 can bind. These results
suggest that Nptx2 spreads through the cortex after it is
secreted by neurons and binds to PNNs.
Next, we analysed the binding mechanism of Nptx2 to
PNNs. We fractionated brain homogenate into four compart-
ments by the application of the sequential buﬀer treatment
puriﬁcation method [3, 9]. This method separates buﬀer-solu-
ble, membrane-associated, charge-bound, and PNN matrix
molecules. Nptx2 was found in themembrane-associated frac-
tion, the charge-bound fraction, and the PNN fraction.
To identify to which PNN molecules Nptx2 can bind,
an ELISA was performed to measure binding to the GAGs
from the four ECM compartments. The GAGs were inves-
tigated since other PNN binding proteins were found to
bind to the GAG chains in the PNN [23, 24] and Nptx2
can be removed from the neuronal surface with chABC
[41]. NPTX2 bound preferentially to PNN GAGs, with
much lower binding to the GAGs from the other fractions.
To investigate the type of GAG bound by NPTX2, we per-
formed enzymatic cleavage on PNN fraction glycans with
chABC, strep hyase, or test hyase. These enzymes reduced
NPTX2 binding, suggesting that the molecule binds to
both CS and HA. These results show that NPTX2 binds
to the PNN and the binding depends on the PNN GAGs.
The same ELISA was then used to measure NPTX2 bind-
ing to puriﬁed glycans, demonstrating strong binding to
both CS-E and HA.
In order to investigate NPTX2 binding to PNNs, we
added tagged NPTX2 to mature cortical neuronal cultures
(which produce PNNs). The NPTX2 associated with WFA-
positive PNNs in culture. Enzymatic treatment with chABC
and strep hyase showed that both enzymes remove WFA
staining for PNNs and also his-tag NPTX2 staining from
9Neural Plasticity
the neuronal surface. These ﬁndings indicate that the tested
enzymes successfully reduce the HA and CS chains in the
PNN, and this reduction leads to the removal of NPTX2 from
the neuronal surface.
A possible eﬀect of NPTX2 on the formation of the PNNs
was investigated in cortical neuronal cultures. When the
medium was enriched with NPTX2, more neurons formed
PNNs by 28DIV and the PNN on these neurons was larger
than on control neurons. These ﬁndings indicate that NPTX2
enhances PNN formation. This is not in accordance with the
ﬁndings presented by [51] that PNNs are unaltered in Nptx2
KO mice. Pelkey et al. showed that there were no alterations
in WFA staining in the adult hippocampus of Nptx2 KO
mice. However, since this experiment was performed in adult
mice only, it is possible that an altered development of PNNs
in the Nptx2 KO animals was missed in this study. It would
be interesting to investigate whether Nptx2 KO mice have
altered PNN development at P7, when the PNN is starting
to be formed and Nptx2 expression peaks.
From the current ﬁndings, it cannot be concluded
through which molecular pathway NPTX2 enhances PNN
formation. Interestingly, another PNN binding protein,
Otx2, also enhances PNN formation [23]. Otx2 binds to the
PNN, and after it enters the neuron, it enhances PNN forma-
tion [23]. Otx2, similar to Nptx2, is not synthesized by the
PNN-bearing neurons but is synthesized instead in the cho-
roid plexus [23]. Nptx2 is also not synthesized by PNN-
bearing PV-INs: Nptx2 is expressed in the cortex by a variety
of interneurons and excitatory neurons. Since Nptx2 expres-
sion is dependent on neuronal activity [39], it is possible that
the activity of excitatory neurons leads to Nptx2 expression
which in turn leads to PNN maturation on the nearby inter-
neurons. Synapses are regulated by the PNN, and both the
PNN and Nptx2 are known to be able to regulate AMPA
receptor mobility [26, 40, 41]. The interaction of Nptx2 with
PNNs may provide a control mechanism for the regulation of
cortical activity by PV-INs. Further investigation is needed to
test this hypothesis.
We identiﬁed in this study Nptx2 as a PNN binding
partner which enhances PNN formation. The binding of
Nptx2 and the PNN provides a new insight into the regula-
tion of PV-INs in the cortex by Nptx2. Nptx2 is known to
have a role in PV-IN maturation and critical period regula-
tion [41, 42, 51]. Here, we presented ﬁndings indicating a
role for Nptx2 in the maturation of PV-INs and PNN con-
densation on the neurons.
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Figure 4: NPTX2 enhances PNN formation. (a) Cortical neurons dissected from E18 rat brains were treated with NPTX2 in their standard
neuronal medium from 14DIV until 28DIV. Neurons were ﬁxed with 4% PFA and stained with WFA combined with parvalbumin (pv)
antibody and his-tag antibody. (a) Representative images of PNN-positive neurons are shown (63x, scale bar = 20 μm). (b) Lower
magniﬁcation images (20x, scale bar = 20μm). (c) The amount of PNN-positive neurons/50mm2 was quantiﬁed and compared between
cultures treated with NPTX2 or not. The number of PNN-positive neurons was signiﬁcantly higher in cultures treated with NPTX2
(p = 0:019). This result indicates that at 28DIV NPTX2 treatment has increased the number of PNN-positive neurons. For each PNN-
positive neuron, the relative size (d) and intensity (e) of their PNN were measured by WFA PNN staining and analysed in ImageJ. It
showed signiﬁcant increase in PNN size in NPTX2-treated cultures (p = 4:72E − 7) and signiﬁcant increase in WFA intensity in NPTX2-
treated cultures (p = 3:93E − 7). These results indicate that NPTX2 treatment caused neurons at 28DIV to be further along in the
development of a fully grown PNN (Student’s t-test).
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Abbreviations
PNN: Perineuronal net
Nptx2: Neuronal pentraxin 2
chABC: Chondroitinase ABC
Strep hyase: Streptomyces hyaluronidase
Test hyase: Testicular hyaluronidase
AMPA: α-Amino-3-hydroxy-5-methyl-4-isoxazolepro-
pionic acid
KO: Knockout
PV-IN: Parvalbumin interneuron
CS: Chondroitin sulphate
HA: Hyaluronan
Otx2: Orthodenticle homeobox 2
Sema3A: Semaphorin-3A
DIV: Days in vitro
GAG: Glycosaminoglycan.
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